ResearcherPost Graduate Institute of Medical Education and ResearchNo recent work listed

Amit Bahl

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1592-0972; OpenAlex author ID A5102923501. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2014: 2 papers

Papers 2

Duodenal toxicity after fractionated chemoradiation for unresectable pancreatic cancer. In Regard to Kelly et al. Co-author DOI 10.1016/j.ijrobp.2013.09.044 ↗
Role of neoadjuvant concurrent chemoradiation in locally advanced unresectable pancreatic cancer: a feasibility study at tertiary care centre. Co-author DOI 10.4103/0019-509x.138295 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Samita Sharma · 1 shared paper, 2014 · strength 0.06
- Paper Duodenal toxicity after fractionated chemoradiation for unresectable pancreatic cancer. In Regard to Kelly et al. DOI 10.1016/j.ijrobp.2013.09.044 ↗
Rajesh Gupta · 1 shared paper, 2014 · strength 0.05
- Paper Role of neoadjuvant concurrent chemoradiation in locally advanced unresectable pancreatic cancer: a feasibility study a… DOI 10.4103/0019-509x.138295 ↗
Sharma Sc · 1 shared paper, 2014 · strength 0.05
- Paper Role of neoadjuvant concurrent chemoradiation in locally advanced unresectable pancreatic cancer: a feasibility study a… DOI 10.4103/0019-509x.138295 ↗
Divya Khosla · 1 shared paper, 2014 · strength 0.05
- Paper Role of neoadjuvant concurrent chemoradiation in locally advanced unresectable pancreatic cancer: a feasibility study a… DOI 10.4103/0019-509x.138295 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.